Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)
Clinical trial NCT04469465 · COMPLETED
Trial details
- NCT number
- NCT04469465
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2022-06-29
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.